NCT06692959
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06692959
Title A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer (Neo-POLEM)
Acronym Neo-POLEM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Southampton
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | AUS

Facility Status City State Zip Country Details
The Queen Elizabeth Hospital RECRUITING Adelaide South Australia Australia Details
St John of God Subiaco Hospital RECRUITING Perth Western Australia Australia Details
Royal Surrey County Hospital NHS Foundation Trust NOT_YET_RECRUITING Guildford Surrey GU2 7XX United Kingdom Details
The Christie NHS Foundation Trust NOT_YET_RECRUITING Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field